Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
Clinical trial NCT05823246 · UNKNOWN
Trial details
- NCT number
- NCT05823246
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2023-10-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.